首页> 美国卫生研究院文献>NeuroRx >EGAR A Food Protein-Derived Tetrapeptide Reduces Seizure Activity in Pentylenetetrazole-Induced Epilepsy Models Through α-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionate Receptors
【2h】

EGAR A Food Protein-Derived Tetrapeptide Reduces Seizure Activity in Pentylenetetrazole-Induced Epilepsy Models Through α-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionate Receptors

机译:EGAR一种食物蛋白衍生的四肽通过α-氨基-3-羟基-5-甲基-4-异恶唑丙酸酯受体降低了戊四唑诱发的癫痫模型的癫痫发作活性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A primary pathogeny of epilepsy is excessive activation of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptors (AMPARs). To find potential molecules to inhibit AMPARs, high-throughput screening was performed in a library of tetrapeptides in silico. Computational results suggest that some tetrapeptides bind stably to the AMPAR. We aligned these sequences of tetrapeptide candidates with those from in vitro digestion of the trout skin protein. Among salmon-derived products, Glu–Gly–Ala–Arg (EGAR) showed a high biological affinity toward AMPAR when tested in silico. Accordingly, natural EGAR was hypothesized to have anticonvulsant activity, and in vitro experiments showed that EGAR selectively inhibited AMPAR-mediated synaptic transmission without affecting the electrophysiological properties of hippocampal pyramidal neurons. In addition, EGAR reduced neuronal spiking in an in vitro seizure model. Moreover, the ability of EGAR to reduce seizures was evaluated in a rodent epilepsy model. Briefer and less severe seizures versus controls were shown after mice were treated with EGAR. In conclusion, the promising experimental results suggest that EGAR inhibitor against AMPARs may be a target for antiepilepsy pharmaceuticals. Epilepsy is a common brain disorder characterized by the occurrence of recurring, unprovoked seizures. Twenty to 30 % of persons with epilepsy do not achieve adequate seizure control with any drug. Here we provide a possibility in which a natural and edible tetrapeptide, EGAR, can act as an antiepileptic agent. We have combined computation with in vitro experiments to show how EGAR modulates epilepsy. We also used an animal model of epilepsy to prove that EGAR can inhibit seizures in vivo. This study suggests EGAR as a potential pharmaceutical for the treatment of epilepsy.Electronic supplementary materialThe online version of this article (doi:10.1007/s13311-016-0489-4) contains supplementary material, which is available to authorized users.
机译:癫痫的主要病因是丙酸α-氨基-3-羟基-5-羟基-5-甲基-4-异恶唑丙酸酯受体(AMPARs)的过度活化。为了找到抑制AMPAR的潜在分子,在计算机模拟四肽库中进行了高通量筛选。计算结果表明一些四肽稳定结合到AMPAR。我们将这些四肽候选序列与鳟鱼皮肤蛋白的体外消化序列进行了比对。在鲑鱼来源的产品中,当通过计算机测试时,Glu-Gly-Ala-Arg(EGAR)对AMPAR具有很高的生物亲和力。因此,假设天然EGAR具有抗惊厥活性,并且体外实验表明EGAR选择性抑制AMPAR介导的突触传递,而不影响海马锥体神经元的电生理特性。另外,在体外癫痫发作模型中,EGAR减少了神经元突增。此外,在啮齿动物癫痫模型中评估了EGAR减少癫痫发作的能力。用EGAR治疗小鼠后,癫痫发作较对照组发作更简短,严重程度较轻。总之,有希望的实验结果表明,抗AMPARs的EGAR抑制剂可能是抗癫痫药物的靶标。癫痫病是一种常见的脑部疾病,其特征是反复发作,无故发作。 20%至30%的癫痫患者无法通过任何药物充分控制癫痫发作。在这里,我们提供了一种天然和可食用的四肽EGAR可以用作抗癫痫药的可能性。我们将计算与体外实验相结合,以显示EGAR如何调节癫痫病。我们还使用了癫痫动物模型来证明EGAR可以抑制体内的癫痫发作。电子补充材料本文的在线版本(doi:10.1007 / s13311-016-0489-4)包含补充材料,授权用户可以使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号